期刊文献+

补体成分在肝脏疾病中诊断应用的新进展 被引量:3

The research progress on diagnostic values and mechanism of complements in liver diseases
原文传递
导出
摘要 补体系统是机体免疫系统的重要组成部分,而肝脏是各类补体成分合成的重要场所,同时补体系统也参与了各种类型肝病的免疫病理过程。血清补体成分的检测对于各类型的肝病具有较高的临床诊断价值。本文阐述了近年来补体系统对各类型肝脏疾病的致病机制及诊断价值的相关研究进展。 The complement system is a part of the immune system and many of the serum complement components are synthesized primarily in the liver. Furthermore, the complement system is also involved in the immune mechanism of pathologic process of liver diseases. The determination of serum complement components level has high clinical diagnostic values for liver diseases. It summarizes the research progress of diagnostic values and mechanism of complement system in liver diseases.
作者 李波 李伯安
机构地区 解放军第三
出处 《中华检验医学杂志》 CAS CSCD 北大核心 2017年第9期652-654,共3页 Chinese Journal of Laboratory Medicine
关键词 肝疾病 补体系统蛋白质类 Liver diseases Complement system proteins
  • 相关文献

参考文献2

二级参考文献61

  • 1周滨,张奉春,董怡.补体C1q及抗C1q抗体与系统性红斑狼疮及狼疮肾炎相关性的研究[J].中华风湿病学杂志,2005,9(12):725-728. 被引量:23
  • 2Chun-Tao Wai,Joel K. Greenson,Robert J. Fontana,John D. Kalbfleisch,Jorge A. Marrero,Hari S. Conjeevaram,Anna S.-F. Lok.A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C[J]. Hepatology . 2003 (2)
  • 3Kamal Ishak,Amelia Baptista,Leonardo Bianchi,Francesco Callea,Jan De Groote,Fred Gudat,Helmut Denk,Valeer Desmet,Gerhard Korb,Roderick N.M. MacSween,M.James Phillips,Bernard G. Portmann,Hemming Poulsen,Peter J. Scheuer,Martin Schmid,Heribert Thaler.Histological grading and staging of chronic hepatitis[J]. Journal of Hepatology . 1995 (6)
  • 4Daniel P Webster,Paul Klenerman,Jane Collier,Katie JM Jeffery.Development of novel treatments for hepatitis C[J]. The Lancet Infectious Diseases . 2009 (2)
  • 5Ta-Chung Wu,Wan-Long Chuang,Chia-Yen Dai,Jee-Fu Huang,Ming-Yen Hsieh,Nai-Jen Hou,Li-Po Lee,Wen-Yi Lin,Jeng-Fu Yang,Chao-Chin Chiu,Shinn-Cherng Chen,Ming-Yuh Hsieh,Wen-Yu Chang,Ming-Lung Yu.Hepatitis C virus infection among children in aboriginal areas in Taiwan[J]. Transactions of the Royal Society of Tropical Medicine and Hygiene . 2008 (9)
  • 6R. Giacchino,F. Bortolotti,G. Indolfi,G. Verucchi,L. Zancan,C. Cammá,L. D’Antiga,M.G. Marazzi,C. Barbera,M. Resti,M. Guido.Antiviral treatment of hepatitis C in Italian children[J]. Digestive and Liver Disease . 2008 (3)
  • 7Cristina Camarero,Natalia Ramos,Alberto Moreno,Angel Asensio,Maria Luisa Mateos,Belen Roldan.Hepatitis C virus infection acquired in childhood[J]. European Journal of Pediatrics . 2008 (2)
  • 8Th.Witth?ft,B.M?ller,K. H.Wiedmann,St.Mauss,R.Link,J.Lohmeyer,M.Lafrenz,C. M.Gelbmann,D.Hüppe,C.Niederau,U.Alshuth.Safety, tolerability and efficacy of peginterferon alpha‐2a and ribavirin in chronic hepatitis C in clinical practice: The German Open Safety Trial[J]. Journal of Viral Hepatitis . 2007 (11)
  • 9K. S.Brown,M. J.Keogh,N.Tagiuri,M. J.Grainge,J. S.Presanis,S. D.Ryder,W. L.Irving,J. K.Ball,R. B.Sim,T. P.Hickling.Severe fibrosis in hepatitis C virus‐infected patients is associated with increased activity of the mannan‐binding lectin (MBL)/MBL‐associated serine protease 1 (MASP‐1) complex[J]. Clinical & Experimental Immunology . 2006 (1)
  • 10Patrick Gerner,Stefan Wirth,Philip Wintermeyer,Alexander Walz,Andreas Jenke.Prevalence of hepatitis C virus infection in children admitted to an urban hospital[J]. Journal of Infection . 2005 (4)

共引文献28

同被引文献27

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部